|Page (1) of 1 - 03/09/17||email article||print page|
Earth Science Tech, Inc. Announces New Cannabis CBD-Based Sports Supplement with Forzagen, Karmavore Superfoods Sales Success, and Company Updates(March 09, 2017)
Hollywood, March 09, 2017 (GLOBE NEWSWIRE) -- Hollywood, March 9, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, is pleased to announce it has formulated a new Cannabis CBD-based pre-workout sports supplement with Forzagen. Additionally, the companys joint venture with Karmavore Superfoods is off to a good start, and their chocolates (infused with ETST CBD) are selling well.
The company recently announced a joint venture with Nutrition Specialties and Forzagen, (Earth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and Forzagen) where Earth Science Tech and Forzagen will formulate new CBD-based sports products. Earth Science Tech will help develop the market in the United States while Forzagen will develop the market in Mexico and other international accounts. Earth Science Tech, together with Forzagen, have formulated a full-spectrum CBD-based pre-workout supplement called Black Demon 2.0. The supplement was formulated for serious athletes, and is incredibly potent. Forzagen and Earth Science Tech will be splitting both the costs and revenues of Black Demon 2.0, and it is currently in the label design phase. It is expected to be bottled and start selling within Q2 or Q3 of 2017.
?We have seen great success with our non-CBD products in the past, but we are expecting even greater success with Black Demon 2.0, said Forzagen owner, Jose Bucay, ?Weve already have competitive athletes testing the supplement, and have nothing but positive feedback in regards to Black Demon 2.0. We think weve got a true hit in the making.
The company recently announced a joint venture with Karmavore Superfoods, (Earth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio Castillo) where Earth Science Tech would help develop sales channels for Karmavores products, while Karmavore would source its cannabis CBD-based ingredients from Earth Science Tech. The initial sales of Kamavore Superfoods CBD infused chocolates under this joint venture have been selling rapidly with great excitement and feedback from store owners and customers. Karmavore Superfoods recently expanded their CBD organic raw chocolate offering with the launch of a new line of CBD peanut butter cups. Initial feedback has been overwhelmingly positive. With nothing like them in the market they are sure to be a game changer in the CBD edibles industry. (http://www.karmavoresuperfoods.com/product-category/hemp-cbd/).
?Weve never seen our products move so quickly, said Brian Miller, owner of Karmavore, ?Its amazing how our specially formulated raw chocolate works with ETSTs CBD oil. Weve truly created a whole new chocolate experience ? and the feedback weve been getting from our customers confirms not just how great the products taste, but more importantly how the CBD chocolate makes them feel. Its a great sign that after only a few weeks of signing this joint venture were already seeing incredible growth. We are looking forward to a long and fruitful relationship with Earth Science Tech.
The company is also hard at work on a new therapeutic, flavored CBD product that will provide consumers with another great tasting CBD oil, while still being all natural having the flavoring provide additional therapeutic benefits. This new product is currently being mixed, and a release plan is expected to be executed before Q3 of 2017.
?We are in a very unique position here, as our company is becoming well-known for its quality and formulation capabilities. Were seeing more and more opportunities coming our way to work with established companies like Karmavore and Forzagen to build mutually beneficial relationships that build sales for both parties, said CSO and Director, Gabriel Aviles, ?This is giving us the opportunity to develop sales channels in places that would have been much harder to reach alone, and its greatly ramping up our operations. We are entertaining offers from international distributors and new potential joint venture partners as we speak.
?With nothing but positive results coming from all of our recent partnerships, we feel were on a great path right now, said President, Director, and COO, Nickolas Tabraue, ?Unfortunately, we are experiencing delays in getting our pet CBD product packaging finished, but we still expect to be ready to launch by Q2 2017. We apologize for the delay, but we are hard at work on expanding our product lines, partnerships, and sales channels to increase shareholder value.
ETST will continuously update our shareholders on the above mentioned product developments, sales, and new joint ventures as further progress occurs.
About Earth Science Tech, Inc. (ETST): Earth Science Tech (www.earthsciencetech.com) is a publicly traded (ETST) unique Science based Biotechnology company focused on cutting edge Nutraceuticals, Bioceuticals, Phytoceuticals and Cosmeceuticals for the Health, Wellness and Alternative Medicine Markets to help improve the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through the use of its cutting edge Nutritional and Dietary Supplements. This may include products such as its High-Grade Hemp CBD (Cannabidiol) Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. ETST High Grade Hemp CBD (Cannabidiol) Oil is classified as "food based" and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants." ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute cannabis industrial hemp based products.
About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide. The company is currently working on finishing the launch of its new corporate website at www.Cannabisthera.com
Some of the R&D that Cannabis Therapeutics will target will be treatments for the conditions and disorders of: Pain, Chronic Pain, PTSD, Breast Cancer, Brain Cancer, Anxiety, Depression, Glaucoma, Crohns disease, Fatty Liver Diseases, Diabetes, Parkinson' s Disease, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), and Drug Addictions among other things. ETST has chosen to target diseases for which, the benefits of Cannabinoids and/or CBD (Cannabidiol) have already been demonstrated by different groups of researchers around the world. However, it is through ETSTs in vitro study with the University of Central Oklahoma and DV Biologics that results confirm the positive effectiveness of Earth Science Techs CBD (Canabidiol) on breast cancer, immune cell function, and human brain cells by acting as a neuroprotectant as shown in its International Application (PCT) for its Provisional Patent. Thus, as a result by mixing natural molecules and generic pharmaceutical drugs with Cannabinoids and/or CBD (Cannabidiol) we intend to increase the effectiveness of Cannabinoids and/or CBD (Cannabidiol) and improve the treatment of different diseases. The 3 cannabis cannabinoid-based nutraceutcial patents and 2 generic pharmaceutical drugs will be based on ETSTs International Application (PCT) for its Provisional Patent named ?Cannabidiol Compositions Including Mixtures and Uses Thereof was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil. This application claims the benefit of ETST U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST U.S. Provisional Application No. 62/102,538, filed January 12, 2015.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Investor Relations Dave Demarest (305)-546-7640 Earth Science Tech, Inc. Nickolas S. Tabraue, P/D/COO (305)-615-2118
Related Sites: DV Format , Oceania , DMN Newswire , CEN - Notebooks , VideoBasedTutorials , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter